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ABSTRACT
Jalali, Aydin M.S.B.M.E., Purdue University, August 2018. Tumor-Osteocyte Inter-
actions Under Fluid Flow Stimulation. Major Professor: Hiroki Yokota.
Bone is one of the most common sites for breast cancer metastasis. Osteocytes
compose approximately 90% of the cell population in bone matrix. Osteocytes are
very sensitive to mechanical stimulation, and physical activities play an essential role
in maintaining bone’s health. Mechanical stimulation can alter the gene expression
profile in osteocytes. However, little is known about the effects of mechanical stim-
ulation on tumor-bone interactions. In this thesis, this question has been addressed:
Does applying mechanical stimulation to osteocytes change tumor-osteocytes interac-
tions? The hypothesis is that mechanical stimulation can change osteocytes secreting
signals and contribute to higher proliferation and migration of tumor cells.
In this thesis, fluid flow-driven shear stress has been used as the mechanical stim-
ulator for osteocytes, and the interactions of tumor-osteocytes, with and without
mechanical stimulation has been investigated. Monolayer cultures and 3D spheroids
of breast cancer cells, including TMD and 4T1 cells were cultured in the conditioned
medium (CM) isolated from MLO-A5 osteocytes, and fluid flow-treated conditioned
medium (FFCM), and their migratory behavior, proliferation, and protein expression
have been evaluated. The results showed that in response to MLO-A5 FFCM, tumor
cells behave differently in Src expression, proliferation, and migration compared to
MLO-A5 CM. As opposed to MLO-A5 CM, FFCM promoted migration, reduced pro-
liferation, and upregulated Src expression in tumor cells. Moreover, by plasmid and
siRNA transfection it has been shown that Src is upstream of Snail and their upreg-
ulation is causing epithelial-mesenchymal transition(EMT) responses in tumor cells.
xii
Furthermore, ELISA concentration assessment showed the involvement of TGF-β in
Src upregulation.
An in vivo study using seventeen mice was conducted to investigate the effect
of mechanical stimulation on clinical conditions. Compressive loads were applied
to tibia after intratibial injection of 4T1.2 cells. The results suggested that direct
mechanical stimulation of metastasized bone, might not be advantageous, and cause
more damage. Furthermore, the results indicated that direct mechanical loading
can make the knee joint more fragile. This research showed mechanical stimulation
can cause tumor cells to behave more migratory in bone microenvironment, and
demonstrated its crucial role in tumor-osteocytes interactions.
11. INTRODUCTION
1.1 Breast Cancer and Metastasis
Breast cancer has the second highest fatality rate among cancers in women [1].
Despite the advances in the recent years, metastatic breast cancer can hardly be cured
in many cases because of its intrinsic heterogeneity and resistance to existing drugs.
The studies have shown that the metastatic cells carry specific biological attributes
of primary tumors in addition to distinct characteristics such as intensified motility,
invasiveness, survival, and resistance to chemotherapy [2]. In the late-stage breast
cancer, several tissues are usually affected by the tumor including bone, liver, and
lung [3]. The metastasis site may depend on varying factors including complementary
adhesive contacts, tumor cells and the stroma molecular interactions and, vascular
flow pattern at the primary tumor site.
The primary tumor cells may experience a series of biological steps to develop
metastatic cells. This process is called a metastatic cascade that includes invasion,
migration, and colonization. Invasion is the first step in this process that happens
with changes in cell-cell and cell-matrix adhesion. Invasion is recognizable with the
switch in cadherin family expression, and extracellular matrix (ECM) degradation [4].
In the next step, tumor cells migrate to distant organs. Studies have shown that there
is two main processes for tumor cells migration, including single-cell and collective-cell
migration. EMT has shown to be essential for mesenchymal-cell migration. In addi-
tion, Rho GTPases seem to be an important factor in amoeboid single-cell migration.
EMT and Rho GTPases increase matrix metalloproteinase (MMP) activation, which
causes more ECM degradation and more invasive stage. During the EMT process,
tumor cells go through multiple changes that lead to invasion including downregula-
tion of epithelial-associated genes and amplification of mesenchymal-genes expression,
2changes in cells cytoskeleton, and loosen cell-cell contact. By EMT, some tumor cells
gain the ability to invade the basement membrane and surrounding stroma, and sub-
sequently, they invade blood or lymphatic vessels. Several mechanisms have been
shown that can promote and control EMT in cancer cells, including Wnt signaling,
Notch signaling, and other molecules including tumor necrosis factor-alpha (TNF-α),
and Src.
Fig. 1.1.: EMT process [5].
Studies have shown that in 50% of breast cancer patients the Wnt signaling is acti-
vated, and its activation is associated with declined overall survival [6]. In most cases,
the canonical Wnt ligands and receptors are overexpressed, while the secreted antag-
onists are silenced. Activation of Wnt/β-catenin pathway leads to Snail expression.
Subsequently, the process causes E-cadherin downregulation and vimentin upregula-
tion. While activation of Wnt signaling is linked to EMT, studies have shown that
3β-catenin expression alone, cannot cause EMT [7]. In addition, osteocytes activate
Wnt signaling through Lrp5/Lrp6 receptors, and cause osteogenic genes in bone-
forming osteoblasts . Lrp5 is a co-receptor known in Frizzled protein family members
and plays an important role in adjusting Wnt signaling and load-driven-bone forma-
tion [8]. Based on Rabbani et al. report, Lrp5 knockdown caused MET-like responses
in prostate cancer cells such as decreased migration, invasion, and increased cell pro-
liferation [9].
Notch signaling is another modulator of Snail expression. Notch signaling reg-
ulates Snail expression through two mechanisms: direct transcriptional activation
of Snail, and the indirect mechanism by lysyl oxidase (LOX). Upregulation of LOX
leads to Snail upregulation, which eventually activates EMT program and induces
migratory and invasive cancer [10,11].
TNF-α is a cytokine, which is involved in various processes in the body, such
as cellular homeostasis, inflammation, and tumor progression. Studies have shown
that TNF-α can block E-cadherin expression while promoting MMP9 expression.
The underlying mechanism is not clear. However, upregulation of Twist-1 has been
hypothesized to be one of the associated factors. In breast cancer patients, upregu-
lation of TNF-α is one of the indicators of invasive cancer [12,13].
Src is a non-receptor tyrosine kinase. Src is one of the critical signaling molecules in
tumorigenesis and is involved in other cell activities, including proliferation, growth,
angiogenesis, motility, adhesion, and survival [14]. Upregulation of Src in tumor
cells is a sign of excessive growth, and metastasis. Studies have shown that Src
interacts with and mediates signaling from multiple cell surface receptors associated
with angiogenesis, and tumor proliferation such as vascular endothelial growth factor
receptor, epidermal growth factor receptor, etc [15, 16]. Based on Saad et al. report,
Src elevation is associated with increased bone metastasis and cancer cell growth in
bone metastases [17]. Moreover, Src upregulation can stimulate PTH-rP production.
For the purpose of this study, two cancer cell lines were used: TMD and 4T1.2
cell lines. TMD tumor cells are a clone of MDA-MB-231 cells. These cells have
4been harvested from a mammary tumor after injecting MDA-MB-231 cells into the
mammary fat of NOD/SCHID mouse. MDA-MB-231 cell line is an epithelial, human
breast cancer cell line, which is extremely invasive and aggressive. This cell line is
triple negative, without detectable expression of estrogen receptor (ER), progesterone
receptor (PR), and human epidermal growth factor receptor 2 (HER2) [18]. 4T1.2
cell line is a clone of 4T1 cells. 4T1 cell line is commonly used in medical research to
mimic the stage IV human breast cancer in the animal model. After injecting 4T1
cells into the mammary pad and creation of spontaneous mammary tumor, 4T1.2
cells were derived from the metastasized bone [3].
1.2 Bone Structure and Remodeling
Bone is comprised of both mineral and organic components. Inorganic hydroxyap-
atite (65%), organic collagen (10%), and water (25%) are the three main components
which create the bone tissue. Among the cartilage, bone is one of the main parts in
the skeletal body system [19]. The skeletal system is mainly responsible to provide
structural support for softer tissues in the body such as lungs, heart, brain, etc. The
other key functionality of the bone is its role in the body movement by being an
attachment and support site for the muscles. Moreover, bone is the main reservoir of
calcium and phosphorus in the body.
There are two primary mechanisms for bone formation; intramembranous ossi-
fication, and endochondral ossification [19]. In intramembranous ossification, the
embryonic tissue or mesenchyme is differentiated into osteoblasts which will develop
the flat bones. In endochondral ossification, first the cartilage model of the bone is
created, and the bone is replaced subsequently. Most of the long bones in the body are
made through the endochondral ossification. The cartilage model of the bone is cre-
ated by condensation of mesenchymal cells, which are differentiated to chondrocytes
afterward [20]. The chondrocytes will secrete different components to form the carti-
lage ECM. Furthermore, the chondrocytes in the center of the model, will grow and
5initiate the calcification process, which leads to their differentiation into osteoblasts.
This process causes the transformation of perichondrium of surrounding cartilage to
the periosteum. As osteoclasts resorb the remaining cartilage, and osteoblasts gen-
erate osteoid forming trabeculae to form the bone structure, the diaphysis initiates
to elongate and creates the medullary cavity. By entering vessels to the ends of the
cartilage model or epiphysis, the secondary ossification centers are formed. Diaphysis
and epiphysis are separated by the growth plate. Growth plate consists of cartilage,
and bone can continue to grow through hypertrophy of the chondrocytes within the
growth plate. Chondrocytes hypertrophy leads to matrix deposition, which allows
osteoblasts to promote matrix and minerals deposition [19].
Bone remodeling is an important mechanism which able the bone to bear tremen-
dous loads in everyday life. Osteoclasts and osteoblasts are the main components
of this process, and their population plays an important role in adjusting it. The
osteoclasts differentiation depends mainly on RANKL/RANK/OPG pathway. The
macrophage colony-stimulating factor (M-CSF), interacts with c-fms which leads to
monocyte progenitor proliferation and expression of receptor activator of nuclear
factor-kB (RANK) [21]. The osteoblasts express RANK ligand (RANKL), which
stimulates the osteoclast differentiation. By RANKL interaction with RANK, the
NF-kB signaling is activated, which causes the mononuclear osteoclasts to express
tartrate-resistant acid phosphatase (TRAP) [19]. While osteoblast can stimulate and
cause osteoclast differentiation by producing RANKL, osteonectin, osteopontin, and
osteocalcin, it can inhibit osteoclast differentiation by limiting receptor osteoprote-
gerin (OPG) [22].
Osteoblasts are derived from two progenitor cells, neural and mesodermal. Briefly,
the runt-related transcription factor 2 (Runx2) modulate gene expressions which en-
code osteocalcin, RANKL, VEGF, dentin matrix protein 1 (DMP1) and sclerostin,
that are responsible for stimulating progenitor cell differentiation into osteoblast lin-
eage [23]. Moreover, growth factors such as fibroblast growth factor (FGF) and
insulin-like growth factor (IGF), angiogenic factors including endothelin-1, hormones
6like prostaglandin agonists and PTH, and bone morphogenetic proteins (BMPs), all
regulate osteoblast differentiation [24].
For the bone remodeling, osteoclasts secret hydrolytic enzymes which can degrade
collagen in the matrix. These enzymes include metalloproteases and cathepsin K, such
as lysosomal hydrolases that degrade the matrix in 2-4 weeks. The degraded mineral
components are removed by the circulation, which leads to the formation of an empty
space called resorption pit [19]. After resorption, osteoclasts go through apoptosis
and are replaced by osteoblasts. Eventually, osteoblasts create the new matrix in 4-6
months. At the end of their life cycle, osteoblasts go through a terminal differentiation
and transform to osteocytes inside the mineralized matrix. The osteocytes maintain
the bone microenvironment balance, control phosphate metabolism, and adjust bone
formation by expressing molecules including FGF 23, DMP1, and sclerostin [25].
1.3 Bone Metastasis and Bone Destruction
Bone has been the most common site for breast cancer metastasis [3]. Usually,
bone metastasis leads to spinal cord compression, extreme pain, hypercalcemia, and
bone fractures. The tradition of chemotherapy has shown to be not effective despite
alleviating the metastasis symptoms for a short period [26]. By expressing chemokines
receptors, tumor cells gain the ability to migrate to specific organs. In addition, bone
matrix is an excellent reservoir for different growth factors such as platelet-derived
growth factors (PDGFs), BMPs , FGFs, and transforming growth factor α and β
(TGF-α and β) [27].
During osteoclastic bone degradation and resorption, most of these growth factors
are released into the marrow. This process can create a chemotactic and attractive
site for tumor cells to grow. Furthermore, bone marrow-derived hematopoietic cells
have the ability to provide premetastatic niche which can facilitate targeted colo-
nization [27]. Many studies have shown how invading of breast cancer cells to the
bone can cause bone degradation in a process called viscous cycle [27]. There are
7four main components that are involved in the vicious cycle which include osteo-
clasts, osteoblasts, mineralized bone matrix, and tumor cells. Due to the production
of different growth factors in the bone microenvironment by tumor cells such as
parathyroid hormone-related protein (PTHrP), the protein expression in the bone
cells change [28]. Notably, the RANKL protein expression is upregulated and OPG
expression is downregulated. These changes lead to more osteoclasts activity and
bone degradation [29]. In addition, cytokines such as IL-6, IL-8, and IL-11 which are
expressed by breast cancer cells can boost the osteoclasts activity. One of the key fac-
tors in bone metastasis osteolysis process is TGF-β [30]. The studies have shown that
TGF-β can active Smad-dependent and Smad-independent signal pathways which can
cause pre-osteolytic factors such as PTHrP to be expressed [27].
1.4 Role of Osteocytes in Bone Metastasis
Over 90% of the cells in a mineralized section of the bone is composed of os-
teocytes which are derived from osteoblasts [31]. Osteocytes play a vital role in
regulating bone homeostasis by adjusting bone formation and resorption in different
conditions. Studies have shown that production of metastatic-mediate factors includ-
ing osteopontin (OPN) and RANKL by osteocytes are upregulated in breast cancer
bone metastasis and accelerate the bone resorption. In addition, osteocytes can af-
fect osteoclasts formation by secreting factors such as RANKL which can activate
osteoclast precursors. Osteocytes activity are not limited to osteoclasts, and studies
have shown that osteocytes can also affect osteoblasts [32]. Osteocytes are the main
mechano-sensors in bone and are responsible for feedbacks to physical stimulation.
For instance, they reduce the production of sclerostin which inhibits bone formation,
in response to physical stimuli. Furthermore, the production of nitric oxide (NO),
and cyclooxygenase 2 (COX2) in osteocytes are decreased due to mechanical stimu-
lation [33]. COX2 have shown to promote osteoblasts formation, and NO considered
to be a molecular messenger in bone intercellular activities [34].
8In recent years, various studies have been conducted to investigate the relation
between osteocytes activity and breast cancer cells. For example, Cui et al. have
used the MLO-Y4 CM effect on MDA-MB-231 cells [31]. Based on their report, CM
can prompt breast cancer cells proliferation. However, it will decrease their migration
capacity. Furthermore, based on Ma et al. report MLO-Y4 CM reduce breast cancer
cells apoptosis [35]. In a study conducted by Chen et al. the MLO-A5 cells which
are another colon of osteocytes, were used to investigate the effect of CM on TMD
spheroids [36]. Based on their report the MLO-A5 CM acts as an attractant for
breast cancer cells. Furthermore, they showed that the CM could shrink cancer cells
3D spheroids, and suggest that osteocytes CM can reverse the EMT in cancer cells
in the bone microenvironment by showing alternations in EMT associated protein
expressions such as Snail downregulation. Several factors in osteocytes CM have
been identified as the leading players in these behavior changes, including biglycan,
osteonectin, and collagen. However, the underlying mechanism has remained unclear
[36].
Fig. 1.2.: Osteocyte condition medium effect on TMD cells.
91.5 Fluid Flow as a Mechanical Stimulator
Bone metabolism is significantly affected by mechanical stimulation [37]. Studies
have shown that by increasing mechanical stress, bone formation increases due to
osteoblast activity. However, as it was mentioned before bone resorption and de-
struction is accelerated by different chronic or acute diseases such as cancer. Many
studies have investigated the effect of mechanical load and strain on osteoblast-like
cells. The results suggested that mechanical strain can stimulate osteogenesis [38].
The unmineralized matrix around the osteocytes in the bone form a porous structure
which allows interstitial fluid to pass for nutrients and waste exchange. The pres-
sure gradients due to compressive forces, stimulate the interstitial fluid through the
lacunar-canalicular porosities which can generate shear stress between 0.8-3 Pa [39].
Therefore, one of the models that have attracted many interests for osteocyte mechan-
otransduction is fluid flow shear stress [40]. Studies have shown that osteoblasts and
osteocytes can sense the fluid shear stress in vitro, and can generate osteocyte re-
sponses which are correlated with bone load in vivo [40]. For instance, production
of prostaglandin E2 (PGE2) and NO, or inclined osteocytes apoptosis [41]. Two dif-
ferent mechanotransducers have been suggested in bone, which are ion channels and
integrin adhesions [42]. Based on Burger et al. report shear stress can cause a rapid
increase in intracellular calcium, which leads to the generation of PGE2 and NO,
which both of them are associated with mechanical stimulation of bone formation in
vivo [41]. By applying shear stress to osteocytes, focal adhesions related signals are
also triggered, such as the interaction between αvβ3 integrin with Shc. In addition,
PGE2 release in osteoblasts is blocked by soluble RGD peptides [43].
Based on Norvell et al. report β-catenin signaling is also affected and changed
by fluid shear stress and mechanical stimulation [44].β-catenin plays an essential role
in osteoblast differentiation and gene expression. The main reason behind this phe-
nomenon has remained unclear, but some possible mechanisms have been suggested
by different studies. For instance, N-cadherin has been shown to be downregulated
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by fluid shear stress in osteocytes [44]. Cadherins that interact with β-catenin can
regulate its signaling by inhibiting the β-catenin interaction between the plasma
membrane and preventing its translocation. N-cadherin has shown to affect cell-
differentiation signaling, including differentiation of cells to osteoblasts lineage [44].
As it was mentioned before, many growth factors are stored in bone. Growth
factors are involved in many mechanisms in bone, including proliferation and differ-
entiation of osteoblasts. Studies on human osteoblast-like cells and primary mouse
osteoblastic cells have shown that fluid shear stress can alter some of these growth
factors production. For instance, TGF-β production increases through cation channel
function [37]. In addition, studies have shown that growth factors such as PDGFs,
bFGF, and TGF-β mRNA expressions have increased in endothelial cells due to the
fluid shear stress application [45,46].
Studies have shown that by applying fluid shear stress to osteocytes in vitro and
changes in bone microenvironment, also changes the cancer cells response. Based on
Ma et al. report, the flow-stimulated osteocytes increase breast cancer cell apopto-
sis [35]. Furthermore, their migration assay results suggested that there is less affinity
between flow-stimulated osteocytes CM and breast cancer cells compared to regular
osteocytes CM. In addition, they showed that flow-stimulated osteocyte decline os-
teoclastogenesis. Even though the results suggested the anti-tumor potential of bone
mechanical stimulation; the underlying mechanism is not well illustrated [35].
1.6 Mechanical Stimulation and Tibia Loading
Breast cancer mostly metastasis to cancellous bone, which is the load bearing
section of the bone. Because of this, bed rest is prescribed for the patients who are
diagnosed with a high risk of fraction [47]. However, bone microenvironment is very
sensitive to mechanical stimulation, and lack of it leads to more bone loss. In contrast,
by stimulating bone the osteoblast activity increases and result in increased bone
production and mass [48]. Studies have shown that physical exercise can improve bone
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strength, decrease bone loss rate, and can be used as adjuvant therapy in breast cancer
patients. In addition, controlled mechanical loading has proven to have beneficial
effects on bone in vivo model. For instance, tibia compression in different models
such as OVX, hormone-deficient osteoporotic, and aged mice can stimulate bone
formation in cancellous bone and prevent bone loss [49, 50]. It is important to note
that, one of the essential parameters in the bone response to mechanical loading is
the strain rate, and should be measured accordingly.
In a recent study conducted by Lynch et al. the effect of tibial compression
on a bone metastases model was investigated [47]. Based on their report, SCID
mice were injected with MDA-MB-231 human breast cancer cells to model the breast
cancer bone metastases, and a 4.1 N compression load was used to make +600 strain
at the medial midshaft of the tibia. 1200 cycles of loads were given at 4 Hz, 5
days/week. Their results showed, tibia compression significantly prevented tumor
formation and prevented osteolytic bone loss in the loaded tibias. The effect of loading
has been hypothesized that can be due to both changes in bone and cancer cells gene
expressions and upregulation of osteoblastic over osteoclastic activity. However, the
exact molecular mechanisms have remained unclear.
1.7 Question and Hypothesis
As it was mentioned before, studies have shown that breast cancer cells behave
differently in the bone microenvironment. However, the effect of mechanical stimu-
lation on bone microenvironment and its effects on tumor-bone interactions has not
been well illustrated. In this study, we aimed to address this question: does apply
mechanical stimulation to osteocytes changes migratory breast cancer cells behav-
ior? To address this question both in vitro and in vivo models were used. In the
in vitro model, MLO-A5 osteocytes were treated with the oscillatory fluid flow, and
migration, proliferation, and gene expression alterations of TMD cells were studied
in response to MLO-A5 conditioned medium with and without fluid flow treatment.
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In the in vivo model, the breast cancer bone metastasis was modeled by tibia in-
jection of 4T1.2 cells to BALB/c female mice. Furthermore, each mouse was treated
with controlled tibia compression in vivo. Because of the Wnt signaling and Src in-
volvement in cells mechanical responses, and their role in cellular proliferation and
migration, we hypothesized that applying oscillatory fluid shear stress to osteocytes
will lead to EMT-like responses in tumor cells. Moreover, we expected mechanical
stimulation promote both migration and proliferation in breast cancer cells.
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2. MATERIALS AND METHODS
2.1 in vitro Analysis
2.1.1 Osteocytes
The MLO-A5 osteocytes were cultured and grown in alpha-minimum essential
medium (αMEM) (Gibco, Carlsbad, CA, USA) containing 5% fetal bovine serum
(FBS), 5% fetal calf serum (FCS), and 1% antibiotics (50units/ml penicillin, and 50
µg/ml streptomycin; Life Technologies, Carlsbad, CA, USA). To keep the differen-
tiation of the osteocytes, the cells were cultured in type I collagen treated (Cat No.
344236, BD Biosciences, San Jose, CA, USA) tissue culture dish (Corning). To ap-
ply fluid shear stress to the cells, it was needed to seed the cells on the glass slides.
The glass slides were cleaned using MiliQ water and autoclaved to kill the remaining
bacteria and remove potential contamination agents. Subsequently, the glass slides
were coated with type I collagen solution (15 µg/ml, 0.02N acetic acid). After ap-
proximately one hour, the collagen was removed, and the glass slides were rinsed
with 1x phosphate buffered saline (PBS) solution. The cells were incubated at 37◦C
temperature with 5% CO2 incubator. To increase the effect of fluid flow on cells 3
hours before applying shear stress, the media was changed to 1% FBS αMEM. For
the fluid flow, MLO-A5 CM containing 1% FBS was used.
2.1.2 Two-dimensional Scratch Assay
To perform the scratch assay, 12-well plates (Corning) were used. After prepa-
ration of the tumor cells, 4 × 105 cells were seeded per well, one day prior to the
experiment using Dulbecco’s modified eagle medium (DMEM) (Corning, Inc., Corn-
ing, NY, USA) containing 10% FBS and 1% antibiotics. The next day, before chang-
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ing the medium to conditioned medium, each well was rinsed using plain DMEM.
Subsequently, 1 mL of conditioned medium was added to each well. The scratch
area was made with a plastic tip. The wound area was monitored, and images were
taken at various time points. The wound area was measured with ImageJ. All of the
two-dimensional scratch assays were done by Yao Fan.
2.1.3 Tumor Spheroids
Human breast cancer cell-derived cell lines, TMD cells were seeded in DMEM
containing 10% FBS and 1% antibiotics. To seed tumor spheroids, after trypsinization
and suspending cells in fresh medium, 200 µL of DMEM with a cell density of 25
cells/µL were added in a U-bottom low-adhesion 96 well plate (S-Bio, Hudson, NH,
USA) and incubated in 37◦C incubator with 5% CO2. The medium was changed to
conditioned medium after 24 hours. The tumor cells were monitored using an optical
microscope and images were analyzed using ImageJ software. The images were taken
on 12 and 24 hours’ time points. All of the tumor spheroids assay were assisted by
Yao Fan.
2.1.4 Three-dimensional Tumor-Bone Fusion Assay
Similar to tumor spheroid assay, MLO-A5 osteocytes, and TMD cells were trypsinized
and prepared. Subsequently, cells were added to a U-bottom low-adhesion 96 well
plate. MLO-A5 spheroids and TMD spheroids were formed in separated wells. After
48 hours, the culture medium was changed to conditioned mediums and spheroids
were carefully transferred to other’s well. The fusion was tracked using an optical mi-
croscope, and the cross-sectional area was measured with ImageJ. Three-dimensional
tumor-bone fusion assay was done by Yao Fan.
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2.1.5 Flow Chambers and Fluid Flow Characteristics
To apply oscillating fluid flow shear stress to the osteocytes, custom-made cham-
bers with parallel plates with a custom-made machine were used. The machine in-
cludes a rotating motor around a fixed shaft, which created the forward and backward
oscillating motion. The device stroke was controlled by changing the rotating axis
offset from the fixed shaft. By connecting an air-sealed syringe to the moving axis of
the device and connecting that to the tube containing MLO-A5 conditioned medium
which was connected to the flow chamber, the oscillating fluid flow was produced.
The flow chamber consists of a polycarbonate plate, a silicone rubber to seal the flow
chamber, and a 75 × 38 mm2 glass slide which had the osteocytes monolayer on one
side. The depth and area of the flow channel were approximately 300 µm and 28.5
cm2, respectively. The fluid flow shear stress was calculated by approximate measure-
ment of the flow rate in the tubes. To measure the shear stress that we applied to
the MLO-A5 osteocytes, we assumed that the cell medium is a Newtonian fluid and
the shear tensor is proportional to the deformation tensor. For steady flow between
infinitely wide parallel plates, wall shear stress is calculated by:
τ =
6µQ
bh2
(2.1)
In which, µ is the dynamic fluid viscosity, b is the width of the chamber and h is
the height of it. Based on this equation, shear stress is a function of fluid flow rate
(Q). For the experiment, the Tygon 3350 silicone tubes were used. The value of the
medium viscosity at 37◦C was obtained from the previous data [51]. Fluid flow was
measured by approximate measurement of the fluid column change (δx) in the silicone
tubes using a digital caliper (0.01 mm accuracy).
Q = Aδx (2.2)
In which A is the inner area of the silicon tube. Based on the companys catalog,
the inner diameter of the silicon tubes was 1
16
inch, and the δx was approximately 30
cm/s.
µ = 0.72mPa, s = 0.72× 10−3Pa.s (2.3)
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Diameter = D =
1
16
in = 0.16cm, radius = r = 0.08cm (2.4)
A = pir2 = 0.02cm2 (2.5)
Q = Aδx = 0.59
cm3
s
(2.6)
b = 3.5cm, h = 0.03cm (2.7)
τ =
6µQ
bh2
=
6× 0.72× 10−3[Pa.s]× 0.59[ cm3
s
]
3.5× 0.032[cm3] = 0.81Pa (2.8)
Prior to each experiment, the flow chambers were cleaned using 1% bleach, 70%
ethanol, and MiliQ water and exposed to UV light for one hour. The silicone rubber
which was used to isolate the flow chamber was autoclaved each time, to prevent the
contamination. To investigate the flow and shear stress effect, 0.2 and 0.8 Pa were
used. As a control for each experiment, one chamber was used with stabile medium
inside the system. After one hour of flow, the MLO-A5 conditioned mediums and
proteins were extracted.
2.1.6 Plasmid and si-RNA Transfection
To overexpress the Snail expression in TMD cells, a plasmid consisting of Snail
coding sequence (SnailHA-pcDNA3; Addgene, Cambridge, MA, USA) was used. The
control group was treated with an empty plasmid vector (FLAG-HA-pcDNA3.1; Ad-
dgen). Moreover, to inhibit Src expression, TMD cells were treated with si-RNA
specific to Src. A negative si-RNA (Silencer Select #1, Life Technologies) was used
for the control group. To transiently transfect the cells, si-RNA was used in Opti-
MEM I medium with Lipofectamine RNAiMAX (Life Technologies). After 24 hours,
the efficiency of si-RNA transfection and plasmid vectors were evaluated by western
blot. Plasmid and si-RNA transfection were assisted by Yao Fan.
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2.2 in vivo Analysis
2.2.1 Animal Preparation
For this study, 17 BALB/c (6 weeks old) female mice were used. The animals were
housed four to five per cage and provided with mouse chow and water ad libitum at
the Indiana University Animal Care Facility in light/dark controlled room. All the
experimental procedures were approved by Indiana University Animal Care and Use
Committee and were in compliant with the Guiding Principles in the Care and Use of
Animals endorsed by the American Physiological Society. Animals were weighed each
day prior to the treatment until sacrifice to evaluate the general health. A summary
of the experimental procedure and timeline is provided in Figure 2.1.
Fig. 2.1.: Timeline of the experimental protocol.
2.2.2 Preparation of Tumor Cells
4T1.2 mouse mammary tumor cells (Dr. R. Anderson, Peter MacCallum Cancer
Institute, Melbourne, Australia) were cultured in DMEM containing 10% FBS and
1% penicillin antibiotics (Life Technologies, Grand Island, NY, USA). The cells were
treated with type I collagen (Corning, NY, USA) and incubated at 37◦C and 5% CO2
humidified incubator. Before the surgery, cells were trypsinized and, suspended in 1x
PBS solution (104 cells/µl) .The cells were kept in ice at 4◦C before injection.
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2.2.3 Bone Metastasis Induction
For the bone metastasis induction, animals were anesthetized using 3% isoflurane,
and the gas flow rate was 0.5-1.0 ml/min. Before the injection, the operation site
was cleaned using 70% ethanol and 10% povidone-iodine. To induce bone metastasis
in the tibia bone, knee has been placed in the flexed position, and 20 µL of 1x PBS
solution with a cell density of 2.5×104 4T1.2 cells/µL was injected directly to the left
tibia plateau using 1 mL insulin syringe while the needle was placed in the marrow
space of the proximal compartment. Animals were given 3 days to recover after the
surgery. All the injections were done by Yao Fan.
2.2.4 Tibia Loading
The tibia loading was performed using Electro Force 3100 (Bose, Inc, Framingham,
MA, USA). Animals were anesthetized prior to the treatment using an anesthetic
induction chamber using 2.5% isoflurane, with approximately 1 ml/min flow rate.
Animals were mask anesthetized during the procedure. The loads were applied in the
axial direction. The left foot was placed on a custom made piezoelectric, and both
foot and the knee joint were fixed. The loads were given every day, 5 minutes every
other day for three weeks using 2 N force (peak-to-peak) at 2 Hz. These conditions
were chosen based on the previous studies [47]. For the placebo group, animals were
anesthetized for 5 minutes in the anesthetic induction chamber and carefully returned
to the cage.
2.3 Data Analysis Procedure
2.3.1 X-ray Imaging
The X-ray images were taken in the Indiana University Animal Care Facility
using Device Faxitron. The imaging process begun after the device calibration. The
harvested bones were thawed at the room temperature. Each bone was placed on the
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Fig. 2.2.: Diagram of tibia between loader and stator, from the side [52].
device platform carefully, and images were taken and recorded. After determination of
region of interest, the images contrast was adjusted using the manufacturer provided
software.
2.3.2 Area and Roughness of Tumor Spheroids
To evaluate the morphological changes in TMD spheroids, images were taken
with the optical microscope at 18 and 24-hour time points after cultivation. The
spheroid images were imported to the ImageJ (v1.51) software and analyzed. Based
on the microscope resolution, each pixel equaled 950 mm. Using Java code, the
tumor spheroid area was measured based on the light contrast. The tumor spheroid
roughness was calculated based on the tumor ellipse and intersect using the formula
below:
Roughness =
tumor spheroid area+ tumor ellipse− 2× tumor intersect
tumor spheroid area
(2.9)
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2.3.3 EdU and MTT Analysis
Tumor cells proliferation rate is one of the important factors that indicates tu-
mor progression. To investigate the proliferation in response to different conditioned
mediums, a fluorescence-based cell proliferation kit was used (Click-iT EdU Alexa
Fluor 488 Imaging Kit; Thermo-Fisher). The cells were seeded 24 hours prior to
EdU incubation. 3 hours after incubating with EdU, the cells were fixed according
to manufacturer provided protocol. Later on, using a confocal microscope (Olympus,
Tokyo, Japan) images were taken, and analyzed by ImageJ.
The MTT analysis was performed to study how the conditioned medium can
affect the tumor cells number and population. A 96 well plate (Corning) and MTT
cell proliferation kit (Invitrogen, Carlsbad, CA, USA) were used. 20µL of TMD cells
suspension in 10% FBS DMEM with a cell density of 150 cells/µL was added to each
well. For each group, 5 wells were used for statistical analysis. After the first day
of seeding, the medium was changed. 2 days after changing the medium, the MTT
solutions were added, and the optical density of the solutions was read by EL800
(BioTek). Subsequently, the data were normalized and analyzed. Both MTT and
EdU analysis were partially assisted by Yao Fan.
2.3.4 Western Blot Analysis
To see how the conditioned mediums change the cells protein expressions, TMD
cells were seeded in a 6-well plates (Corning), 2 × 105 cells/well, one day prior to
medium exchange. The cells were cultured in DMEM containing 10% FBS, and 1%
antibiotics. Before exchanging the mediums to conditioned mediums, each well was
rinsed with plain DMEM.
To extract the proteins from the cells radioimmunoprecipitation assay (RIPA)
buffer solution containing phatase (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and protease inhibitors (Cadlibiochem, Billerica, MA, USA) was used to lyse the cells.
In addition, the protein solution was sonicated to lyse the remaining cells in the solu-
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tion. Subsequently, the extracted proteins were separated using 10% SDS gels during
gel electrophoresis procedure and transferred to Immobilon-P membranes (Millipore,
Billerica, MA, USA). The membranes were cut based on the protein weight and incu-
bated with the first antibody. The first antibody incubation time was dependent on
the protein type. Afterwards, the membranes were incubated with either anti-rabbit
or anti-mouse IgG conjugated with horseradish peroxidase for 45 minutes. Proteins
were detected using SuperSignal West Femto maximum sensitivity substrate (Thermo
Scientific). The images were analyzed by a luminescent image analyzer (LAS-3000,
Fuji Film, Tokyo, Japan). All of the western blot figures were supported by Yao Fan.
2.3.5 ELISA Analysis
It was hypothesized that TGF-β could be one on the potential stimulators of
the changes in TMD cells behavior. To measure the concentration of TGF-β in the
conditioned mediums a TGF-β ELISA kit (TGF beta-1 Human/Mouse Uncoated
ELISA Kit, Thermo Scientific) was used. A 96 well plate (Corning) was used for 4
groups of samples; standard solution, control, MLO-A5 CM, and MLO-A5 FFCM.
The procedure was done based on the manufacturer provided instruction. 30 minutes
after adding ELISA solution, the optical density of the solutions was read by EL800
(BioTek). Subsequently, after normalization of the optical densities based on the
manufacturer provided standard solution, the TGF-β concentration in samples was
calculated.
2.3.6 Fluorescence Resonance Energy Transfer (FRET)
To monitor the Src activities in lipid rafts of plasma (Lyn-Src), and the cytosol
(Cyto-Src), FRET-based, cyan fluorescent protein (CFP)-yellow fluorescent protein
(YFP) biosensors were used. A Cyto-Src includes four main components which are
CFP, YFP, a truncated Src substrate peptide, and an effector protein binding domain.
Lyn-Src is synthesized by the combination of Lyn kinase and N-terminal of Cyto-Src
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biosensor. Src activation leads to increased interaction and binding of the effector
protein binding domain to the truncated Src domain. These interactions cause a
conformational change in the biosensor and incline the FRET efficiency from CFP
to YFP. Therefore, Src activity can be monitored by changes in the emission ratio of
the CFP to YFP.
A Nikon Ti-E inverted microscope was used for taking images. Three filters were
used for the imaging process including YFP (FRET) emission (542/27), CFP excita-
tion (438/24), and CFP emission (483/32). To maintain the focus during time-lapse
imaging, the microscope was equipped with a Perfect Focus System (Nikon). In ad-
dition, a 100 W Hg lamp with an ND64 neutral density filter was used to lessen pho-
tobleaching. To generate Src activity FRET images, the emission ratio of CFP/YFP
for a single cell was measured by NIS-Elements software (Nikon). To quantify the
Src activity based on the FRET responses, the discrete time associated derivatives
of the emission ratios, Y, was calculated. It was assumed that the rate of FRET
ratio change in response to cytokines follows a Gaussian distribution. Furthermore,
Y related curve was fitted using Gaussian functions:
Y = A× exp(−0.5× (t− µ)
σ2
) (2.10)
In which A is the maximal rate of FRET ratio, µ is the time when the rate of
FRET ratio change reaches the maximal value, and σ is the duration of the rate of
FRET ratio change.
2.3.7 Mechanical Testing (in vivo and ex vivo)
After euthanasia tibia was harvested and kept in 1x PBS solution at -20◦C freezer.
Before mechanical testing, tibia bones were brought to the room temperature and kept
in 1x PBS solution to keep hydrated. To evaluate tibia bone mechanical properties,
in vivo, and ex vivo assessments were performed. For all the mechanical evaluations
Electro Force 3100 device was used. 2 days in each week were chosen to evaluate
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the tibia stiffness in vivo by axial loading measurement. The test was performed
on Tuesdays and Fridays of each week until sacrifice. After sacrifice, both axial
stiffness and bending stiffness were measured. To evaluate the bending stiffness,
standard 3-point bending method was used. Briefly, bones were thawed at the room
temperature. Subsequently, the tibia length was measured from the intercondylar
eminence to medial malleolus using a 0.01mm caliper. The posterior midshaft was
marked, and bone was fixed from proximal and distal tibia points. An oscillating
1N peak-to-peak force, with 1Hz frequency, was applied for 15 seconds to the medial
midshaft of the tibia in the anterior-posterior direction. The support span length
was 6 mm. To measure the axial stiffness, two rounded-top mounts were used on the
machine. The intercondylar eminence and medial malleolus of the tibia were fixed
on the mounts, and the loads were given in the axial direction with the previously
described characteristics.
The displacements and the force changes were recorded using the manufacturer
software. To calculate the stiffness, the force-displacement data was imported to
MATLAB. The bone stiffness was calculated based on the force-displacement curve
in a specific force range where the curve changes were linear. The mechanical loads
were applied five times in each run, and the average stiffness from the last three times
was measured and presented as the bone’s stiffness. All the process were performed
using a custom-made MATLAB script.
2.3.8 Micro-CT
Miro computed topography images were taken using Skyscan 1170, at Indiana
University School of Medicine. All the bones were brought to the room temperature
and wrapped in Parafilm to keep hydrated. The images were taken with a medium
sized camera with 8.9 voxel resolution. Two hydroxyapatite phantoms (0.25 and 0.75
g/cm3) were used for calibration, to measure the bone mineral density (BMD) and
grayscale values. The images were reconstructed and rotated using NRecon v1.6.9.15
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Fig. 2.3.: Diagram of tibia mechanical testing and span size.
and DataViewer v1.5.0 software, respectively. The regions of interest were manually
determined for trabecular and cortical bones, and the analysis was performed using
CTAn v1.11.4.2 software. Cancellous volume of interest was determined 0.5mm distal
to the growth plate and extended to 10% of the tibia length [53].
2.4 Statistical Analysis
For all the quantitative data, the standard deviation and mean were calculated.
For statistical group comparisons, the Students t-test was used. The post hoc values
were used as the primary tool to detect significant differences between groups. The
statistical significances have been shown using (*) and (**) for p-values less than 0.05
and 0.01, respectively. The outliers were detected and removed by Grubbs' test when
the significance probability was less than 0.05.
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3. RESULTS
3.1 Effect of MLO-A5 CM on TMD Cells
3.1.1 MLO-A5 CM Inhibited TMD Cells Migration
To investigate how MLO-A5 CM alters the TMD cells migration behavior, 2-
dimensional wound healing scratch assay was conducted. As the Figure 3.1 shows,
the results revealed that the MLO-A5 CM inhibited the TMD cells migration. The
results showed that the wound area of the samples, which were treated with MLO-A5
CM, was significantly larger than the control samples. At 24-hour time point, the
average wound area of the treated samples was 92% larger than the control group
(p<0.05).
Fig. 3.1.: Effect of MLO-A5 CM on TMD cell migration. (A&B) Lower motility of
TMD cells in the presence of MLO-A5 CM.
26
3.1.2 MLO-A5 CM Decreased Tumor Spheroid Area and Roughness
As the second indicator of behavior and morphology changes of TMD cells in
the presence MLO-A5 CM, 3-dimentional tumor spheroid assay was conducted. As
the Figure 3.2 shows, after 24 hours, the mean tumor spheroid area of the MLO-
A5 CM treated group was significantly smaller than the control group. The mean
tumor spheroids roughness was also measured. Even though no statistically significant
changes were seen in the spheroids roughness, the trend was consistent with the
spheroids area.
Fig. 3.2.: Effect of MLO-A5 CM on TMD spheroids formation. (A) Representative
images of TMD spheroids with and without the presence of MLO-A5 CM. (B) Two
spheroid parameters (cross-sectional area, and roughness).
3.1.3 Protein Expression, and Cell Proliferation Analysis
To investigate how MLO-A5 CM is affecting the TMD cells protein expressions
related to EMT, expression of proteins including Snail, p-Akt, and Akt were measured
through western blotting. The results revealed that the Snail expression of TMD cells
is downregulated after incubation with MLO-A5 CM. On the contrary, Akt and p-Akt
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were both upregulated by the MLO-A5 CM. The β-actin expression was consistent
through all the samples.
By using EdU assay relative cell growth and proliferation of TMD cells in the
presence of MLO-A5 CM was compared to no treated group. The results illustrated
that MLO-A5 CM increased TMD cells proliferation. As it is shown in Figure 3.3,
the relative proliferation of TMD cells was increased close to 10% in the presence of
MLO-A5 CM (p<0.05).
Moreover, MTT assay was conducted to study the effect of MLO-A5 CM on
TMD cells growth and proliferation. As the results in Figure3.3 show, the TMD
cells proliferation is significantly increased in MLO-A5 CM. Based on the results, the
proliferation of tumor cells in osteocytes conditioned medium increased up to more
than 70% (p<0.01).
Fig. 3.3.: Effect of MLO-A5 CM on TMD cells protein expression, cell growth, and
proliferation. (A) Representative images of fluorescence EdU cell proliferation assay
in the presence of MLO-A5 CM. (B) MLO-A5 CM increased both TMD cells
relative growth, and proliferation. (C) Protein levels of Snail, p-Akt, and Akt in
response to MLO-A5 CM.
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3.2 Effect of MLO-A5 FFCM on TMD Cells
3.2.1 MLO-A5 FFCM Promoted TMD Cells Migration
To investigate the migratory behavior of TMD cells with MLO-A5 FFCM and
compared it to MLO-A5 CM, the 2-dimensional motility scratch assay on TMD cells
using both MLO-A5 conditioned medium with and without fluid flow treatment was
conducted. The results revealed that opposite to MLO-A5 CM, MLO-A5 FFCM
promoted tumor cells migration. Based on the results which are shown in Figure 3.4
the wound area of TMD cells which were treated with MLO-A5 FFCM (0.8 Pa) was
34% smaller than the no-flow group (0 Pa) after 24 hours (p<0.05).
Fig. 3.4.: Effect of MLO-A5 FFCM on TMD cells migration. (A&B) Higher motility
of TMD cells in the presence of MLO-A5 FFCM compare to no-flow treated
conditioned medium.
3.2.2 MLO-A5 FFCM Increased Tumor Spheroid Area and Roughness
3-dimensional tumor spheroid assay was used as another indicator of tumor cells
migratory behavior in response to the conditioned medium. The morphology changes
of 3D tumor spheroids were screened for 24 hours. The area of tumor spheroids which
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were treated with MLO-A5 FFCM (0.8 Pa) was significantly larger than the no-flow
treated group (p<0.05).
Fig. 3.5.: Effect of MLO-A5 FFCM on TMD spheroids formation. (A)
Representative images of TMD spheroids in the presence of MLO-A5 CM with and
without fluid flow treatment. (B) Higher cross-sectional area of TMD spheroids in
the presence of MLO-A5 FFCM compare to no-flow treated samples.
3.2.3 Protein Expression, and Cell Proliferation Analysis
As it is shown in Figure 3.6. the western blot protein analysis results revealed that
compared to no flow, Snail expression of TMD cells is upregulated by MLO-A5 FFCM.
The p-Akt and Akt expressions were also measured, and results showed that when
MLO-A5 osteocytes are treated with oscillating fluid flow shear stress the conditioned
medium can downregulate the p-Akt expression of tumor cells in opposite to MLO-A5
CM. The Akt expression has remained constant, and β-actin had the same expression
level, and it was consistent for both groups.
Consistent to p-Akt downregulation, the MTT and EdU assays results revealed
that TMD cells proliferation, and growth were also decreased significantly in the
presence of MLO-A5 FFCM. As the Figure 3.6 shows, the cell number of tumor
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cells in the presence of MLO-A5 FFCM was 40% smaller than no-flow treated group
(p<0.01).
Fig. 3.6.: Effect of MLO-A5 FFCM on TMD cells protein expression, cell growth,
and proliferation. (A) Representative images of fluorescence EdU cell proliferation
assay in the presence of MLO-A5 FFCM. (B) MLO-A5 FFCM decreased both TMD
cells proliferation, and relative population. (C) Protein levels of Snail, p-Akt, and
Akt in response to MLO-A5 FFCM.
3.3 Effect of MLO-A5 FFCM with Lower Fluid Flow Shear Stress
To study the effect of fluid flow shear stress on MLO-A5 osteocytes and its inter-
actions with TMD cells more deeply, the experiment was conducted with the same
procedure. However, the fluid flow shear stress was decreased to 0.2 Pa.
3.3.1 MLO-A5 FFCM Promoted TMD Cells Migration
A 2-dimensional scratch motility assay was conducted on TMD cells using the flow
and no-flow treated conditioned mediums. The results revealed that after 24 hours
TMD cells which were treated with FFCM had significantly smaller wound area. As
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the results are shown in Figure 3.7. The wound area of MLO-A5 FFCM (0.2 Pa) was
33% smaller than no-flow treated (0 Pa).
Fig. 3.7.: Effect of low shear stress MLO-A5 FFCM on TMD cells migration. (A&B)
Higher TMD cells motility in the presence of low shear stress MLO-A5 FFCM
compare to no-flow treated MLO-A5 CM based on a 2-dimensional scratch assay.
3.3.2 Protein Expression, and Cell Proliferation Analysis
To further examine the effect of low shear stress MLO-A5 FFCM on TMD cells,
MTT and protein analysis were also performed. The results revealed that the effect of
MLO-A5 FFCM on tumor cells proliferation, with both high and low shear stresses
(0.2 and 0.8 Pa) is the same. As the Figure 3.8 shows, the MLO-A5 FFCM with
0.2 Pa shear stress has also decreased the growth and proliferation of tumor cells.
Moreover, the western blot analysis showed that Snail expression is upregulated due
to the use of MLO-A5 FFCM, and p-Akt expression is downregulated.
3.4 Effect of MLO-A5 Conditioned Mediums on 4T1 Cells
The effect of MLO-A5 FFCM on TMD cells, showed interesting results. However,
different cancer cell types might react differently to the conditioned medium. To
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Fig. 3.8.: Effect of low shear stress MLO-A5 FFCM on TMD cells protein
expression, and cell proliferation. (A) Representative images of TMD cells
proliferation in the presence of low shear stress MLO-A5 FFCM, at 0 and 48 hours
time points based on MTT assay. (B) Lower relative TMD cells proliferation in the
presence of lower shear stress MLO-A5 FFCM. (C) Protein levels of Snail, p-Akt,
and Akt in response to low shear stress MLO-A5 FFCM.
investigate the effect of MLO-A5 conditioned mediums on other cell types, the same
assays were replicated using 4T1 cells.
3.4.1 MLO-A5 CM Inhibited 4T1 Cells Migration
As it was mentioned before, MLO-A5 conditioned medium inhibited TMD cells
migration. The same 2-dimensional scratch motility assay was conducted on 4T1
cells. The results showed that after 12 hours the control group of 4T1 cells had
significantly smaller wound area than MLO-A5 conditioned medium treated group.
As it is shown in Figure 3.9. 4T1 cells behave comparable to TMD cells in this assay.
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Fig. 3.9.: Effect of MLO-A5 CM and FFCM on 4T1 cells migration. (A&B) Lower
motility of 4T1 cells in the presence of MLO-A5 CM based on 2-dimensional scratch
assay. (C) Smaller wound area of 4T1 cells in the presence of MLO-A5 FFCM
compared to no-flow treated conditioned medium based on 2-dimensional scratch
assay.
3.4.2 MLO-A5 FFCM Promoted Migration in 4T1 Cells
2-dimensional wound healing scratch assay was conducted on 4T1 cells using MLO-
A5 FFCM and no-flow treated MLO-A5 CM. The results indicated that 4T1 cells
behave similar to TMD cells, and MLO-A5 FFCM increased the 4T1 cells motility
compare to no-flow treated conditioned medium. After 12 hours, the relative wound
area of the no-flow treated conditioned medium was 15% larger than the MLO-A5
FFCM.
3.4.3 Protein Expression, and Cell Proliferation Analysis
As it is shown in Figure 3.10, MTT analysis results revealed that MLO-A5 FFCM
also decreased the proliferation rate in 4T1 cells. In addition, Snail, p-Akt, and Akt
protein expressions in 4T1 cells were measured in response to flow and no-flow treat
MLO-A5 conditioned medium. As similar to TMD cells, the results showed that
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the Snail protein expression was downregulated by MLO-A5 CM, and upregulated
by MLO-A5 FFCM. On the contrary, p-Akt expression was downregulated by no-
flow treated MLO-A5 CM and upregulated by MLO-A5 FFCM. Akt expression was
similar in both groups and no differences were seen.
Fig. 3.10.: Effect of MLO-A5 conditioned mediums on 4T1 cells protein expression,
and proliferation. (A) Decreased proliferation of 4T1 cells in the presence of
MLO-A5 FFCM based on MTT assay. (B) Protein level of Snail, p-Akt, and Akt of
4T1 cells in response to MLO-A5 CM, and FFCM.
3.5 Wnt Signaling
As it was mentioned before, one of the possible reasons for EMT in breast cancer
cells is the activation of Wnt signaling. To investigate this phenomena, Wnt3a which
is a canonical Wnt signaling pathway activator, and XAV-939 which is a Wnt signaling
inhibitor were used.
3.5.1 Effect of Wnt Signaling on Tumor Spheroid Area and Roughness
To study the effect of Wnt signaling on 3-dimensional tumor spheroids and com-
parison to MLO-A5 CM, and FFCM, Wnt activator and inhibitor were added to TMD
cells culture medium. The result revealed that the addition of Wnt3a increased tumor
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spheroid area and roughness significantly. Furthermore, XAV significantly decreased
tumor spheroid area, however, there was no significant difference in their roughness.
These results suggested that in the presence of Wnt3a, tumor cells behaved more
migratory. In addition, by inhibiting Wnt signaling in TMD cells, they became more
stationary.
Fig. 3.11.: Effect of Wnt signaling on TMD spheroids formation. (A&B)
Representative images of TMD spheroids, Wnt3a and XAV treated TMD cells after
72 hours. (B) Changes in two spheroid parameters (cross-sectional area, and
roughness, respectively) by Wnt3a and XAV after 72 hours.
3.5.2 Effect of Wnt Signaling on TMD Cells Migration
2-dimensional wound healing scratch assay was performed by along with the addi-
tion of Wnt3a and XAV to the TMD cells culture medium, in order to further analysis
the effect of Wnt signaling on tumor cells behavior. As it is shown in Figure 3.12 after
24 hours the relative wound area of the Wnt3a treated group was significantly smaller
than the control group, and as the previous 3-dimensional tumor spheroid data in-
dicated, Wnt3a promoted migration in TMD cells. Furthermore, the relative wound
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area of XAV treated group was 20% larger than the control group, and inhibition of
Wnt signaling decreased tumor cells motility.
Fig. 3.12.: Effect of Wnt signaling on TMD cells motility and migration. (A&B)
Promotion and inhibition of TMD cells migration by Wnt3a and XAV, respectively.
3.5.3 Protein Expression, and Cell Proliferation Analysis
The results from MTT analysis showed that Wnt signaling can also alter the
proliferation rate in tumor cells. As the results in Figure 3.12 show, by blocking
Wnt signaling the relative proliferation of TMD cells was decreased more than 30%
(p<0.01). On the other hand, results indicated that by stimulating and activating
Wnt signaling by Wnt3a, relative proliferation of tumor cells increased significantly
(p<0.05).
To compare the effect of Wnt signaling with MLO-A5 CM, and FFCM, TMD
cells Wnt signaling associated protein expression levels were measured through west-
ern blotting. Based on the results, Snail, and p-Akt expressions were upregulated
by Wnt3a and down-regulated by XAV. On the contrary, Lrp5 expression was down-
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regulated by Wnt3a and upregulated by XAV. The Akt expression was similar in all
groups. In addition, the TMD cells Lrp5 expression was downregulated by MLO-A5
conditioned medium. Furthermore, the results revealed that Lrp5 expression level was
upregulated by MLO-A5 FFCM. However, β-catenin expression level which is one of
the main proteins in Wnt signaling pathway is slightly downregulated by MLO-A5
FFCM. No significant change was seen in p-β-catenin and p-NFκB expression levels.
Fig. 3.13.: Effect of Wnt signaling on TMD cells protein expression, and
proliferation. (A) Increased relative proliferation of TMD cells by Wnt3a, and
decreased by XAV based on MTT assay. (B) Protein level of Wnt signaling
associated proteins of TMD cells in response to Wnt3a and XAV. (C) Protein level
of Wnt signaling associated proteins of TMD cells in response to MLO-A5 CM, and
FFCM.
3.6 Src and Snail Pathways
3.6.1 Effect of MLO-A5 CM on Src Expression
Snail expression in tumor cells has shown to be upregulated by MLO-A5 FFCM.
As it was mentioned before Snail is one of the main proteins indicating EMT in cancer
cells. To further understand the mechanism behind the EMT in TMD cells due to
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incubation with MLO-A5 FFCM, the Src, and FAK expressions of TMD cells were
measured in response to MLO-A5 CM, and FFCM. Based on the results p-Src was
downregulated in tumor cells by MLO-A5 conditioned medium. However, no changes
were seen in the FAK or p-FAK expressions. Moreover, the results indicated that
p-Src is upregulated by the MLO-A5 FFCM, but FAK and p-FAK expressions were
not changed by the flow treated conditioned medium.
Fig. 3.14.: Effect of MLO-A5 CM, and FFCM on Src and FAK expressions. (A&B)
Protein level of Src and FAK of TMD cells in response to MLO-A5 CM, and FFCM.
3.6.2 Src and Snail Pathway
Since the changes in expression of Snail and Src in TMD cells in response to con-
ditioned mediums were similar, the relation between Src and Snail was investigated.
For this purpose, Snail plasmid and si-RNA specific to Src were used. The results
revealed that Src is upstream of Snail. As it can be seen in Figure 3.15, by Snail
plasmid transfection, Snail expression is upregulated, however, no changes in p-Src
and Src were detectable. In contrary, the results showed that by Src knockdown,
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Snail expression is inhibited. Furthermore, Src knockdown promoted Lrp5 expression
in TMD cells.
Fig. 3.15.: Src is upstream of Snail and Lrp5 inhibitor. (A) Increased expression of
Snail and decreased expression of p-Akt in TMD cells by Snail plasmid. (B)
Decreased expression of Src and Snail, and increased expression of p-Akt and Lrp5
by knockdown of Src in TMD cells.
3.6.3 Effect of Src and Snail on TMD Cells Migration
To test our hypothesis and study the relation between Snail and Src expression on
breast cancer cells migratory behavior, a 2-dimensional wound healing scratch assay
was conducted using Snail plasmid and siRNA specific to Src. As it is shown in Figure
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3.16 Snail plasmid promoted migration significantly, and the relative wound area after
24 hour was significantly smaller than the control group (p<0.05). Furthermore, the
results indicated that silencing Src expression using si-RNA inhibited tumor cells
migration. Relative wound area of Src siRNA treated group were 45% larger than
the control group (p<0.01).
Fig. 3.16.: Effect of Src and Snail on TMD cells migration. (A&B) Higher motility
of TMD cells by Snail plasmid transfection. (C&D) Lower motility of TMD cells by
Src knockdown.
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3.7 Src Activity Screening by FRET
Based on the previous results, the relation and involvement of Src in upregulation
of Snail and tumor cells responses was established. To further investigate the Src
activity, a Cyto-Src FRET biosensor was used to study the Src cytoplasmic activity
in real-time. Figure 3.17 represents the FRET measurements. The results from FRET
measurement confirmed that the Src activity is downregulated with A5 CM, while
flow treatment prevents MLO-A5 CM downregulation of Src in TMD cells. Collagen
was used as an Src suppressor agent and positive control.
3.8 Effect of MLO-A5 CM and FFCM on Tumor-Bone Infusion
A 3-dimensional spheroid fusion assay was used to investigate the effect of MLO-
A5 conditioned medium, with and without flow treatment, on the rate and efficacy
of tumor-osteocytes spheroids diffusion. As it is shown in Figure 3.18, after 72 hours,
cross-sectional area of MLO-A5 CM treated samples was significantly smaller than
MLO-A5 FFCM treated ones. Which implies that in the presence of MLO-A5 FFCM
tumor cells behave more migratory, and aggressive compared to MLO-A5 CM.
3.9 Effect of Fluid Flow Treatment on MLO-A5 Osteocytes
To investigate how fluid flow treatment changes the conditioned medium efficacy
and tumor-osteocytes interactions, osteocytes proteins were harvested directly after
the treatment. Subsequently, by western blot analysis, it was illustrated that TGF-β
expression was upregulated in MLO-A5 osteocytes which were treated with fluid flow.
Furthermore, by using ELISA kit, TGF-β concentration in MLO-A5 CM and FFCM,
was measured. As the results in Figure 3.19 show, the relative TGF-β concentration
was significantly higher in MLO-A5 FFCM than no-flow treated conditioned medium.
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Fig. 3.17.: : Differential dynamics of Cyto-Src activation in TMD cells by collagen,
MLO-A5 CM, and FFCM. (A) Src activities in response to the addition of collagen,
and presence of MLO-A5 CM, and FFCM. (B) The FRET ratio images and time
course of Cyto-Src activities in response to the addition of collagen, and presence of
MLO-A5 CM, and FFCM.
3.10 Effect of TGF-β on p-Src and Snail Expression in TMD Cell
As it was mentioned before, cytokines can promote tumor progression and con-
tribute to invasion and migration. Previous results indicated that TGF-β concentra-
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Fig. 3.18.: Effect of MLO-A5 CM and FFCM on tumor-bone diffusion. (A) Higher
tumor-bone diffusion rate in the presence of MLO-A5 FFCM than MLO-A5 CM.
(B) changes in TMD spheroids cross-sectional area in the presence of MLO-A5 CM
and FFCM.
tion is increased due to the flow treatment in MLO-A5 FFCM. To investigate the
effect of TGF-β on tumor cells protein expression, 10 and 100 ng/ml of TGF-β1 and
TGF-β3 were added to the TMD cells culture medium, separately. As the results in
Figure 3.20 show, the Snail expression is upregulated in all cases. The results revealed
that p-Src expression did not change with TGF-β1 addition. However, addition of
TGF-β3 promoted the p-Src expression in TMD cells in a dose-dependent manner.
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Fig. 3.19.: Effect of fluid flow treatment on MLO-A5 osteocytes. (A) Relative
Higher concentration of TGF-β in MLO-A5 FFCM than MLO-A5 CM and control
based on ELISA assay. (B) Protein level of TGF-β in MLO-A5 osteocytes with and
without fluid flow treatment.
Fig. 3.20.: Effect of TGF-β on p-Src and Snail expression in TMD cells. Protein
level of Snail and p-Src in response to the addition of TGF-β1 and TGF-β3 in TMD
cells.
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3.11 Tibia Loading and Bone Metastasis
3.11.1 Mice Bodyweight
With the beginning of the treatment, the mice body weight was measured every
day after loading for three weeks until sacrifice. At the initiation of the tibia loading,
the mean body weight for the sham loading mice was 18.29 ± 0.69 gr, and the
loading group was 18.25 ± 0.86 gr. As the Figure 3.21 shows, the body weights did
not change significantly in either group throughout the study, and the body weights
were remained within the expected range based on the age, sex, and condition.
Fig. 3.21.: Mice bodyweight during treatment period.
3.11.2 Bone Phenotype and Mechanical Properties
As it is shown in Figure 3.22, tumor induction in mouse tibia caused significant
structural changes in bone. To investigate the changes, µCT and X-ray images were
taken from tibia. By using µCT images, the cross-sectional image of proximal regions
of the tibia were extracted. The X-ray images suggested that loading mice knee
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joint is more fragile than the sham loading group. In addition, loading mice tibia
bones showed more smoother shaft than sham loading group. Furthermore, the µCT
results revealed the osteoblastic regions are more detectable in sham loading mice.
However, these osteoblastic regions were accompanied with architectural deterioration
of bone structure and morphological bone degeneration. Also, the cross-sectional
images indicated that more discontinuity and osteolysis occured in the loading mice.
As it is shown in Figure 3.23 bending stiffness of the loading mice tibia ex vivo
was 23% higher than sham loading mice, but not statistically significant (p=0.18).
Moreover, axial stiffness was also measured. However, no significant difference were
seen between the groups.
Fig. 3.22.: Effect of tumor induction on bone topography.(A) Representative X-ray
images of sham loading and loading tumor induced tibia bones after harvest. (B)
Representative cross-sectional µCT images of osteoblastic and osteolytic regions of
tibia bone in sham loading and loading mice.
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Fig. 3.23.: Tibia mechanical properties (ex vivo assesment). (A&B) Two parameters
of bone mechanical properties (axial stiffness, and bending stiffness) ex vivo.
3.11.3 Tumor-Mediated Bone Degradation and Loading Effect
The results showed that percent bone volume (BV)/tissue volume (TV) of the
sham loading was significantly better than the loading mice (p¡0.05). Furthermore,
bone mineral density was measured. Even though, no statistically significant differ-
ences were seen between the groups, the results trend suggested that sham loading
mice tibia bone has higher bone mineral density compared to loading mice. Based on
the results, the bone mineral density of the sham loading mice tibia was 6% higher
than loading mice tibia (p=0.09). Furthermore, to quantify the bone loss at the knee
region, the bone volume was measured. The results showed significant smaller bone
volume for loading mice compared to sham loading. Overall, the results trend showed
higher bone loss and architectural destruction in loading mice than sham loading.
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Fig. 3.24.: Bone mass and architecture evaluation by µCT. (AB) Representative 3D
reconstructed µCT images of tibia bone and the regions of interest. (B-D) Three
tibia bone structural parameters (bone volume, percent BV/TV, cortical BMD) by
µCT.
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4. DISCUSSION
This thesis presented how FF treatment on osteocytes can change breast can-
cer cells interaction with bone microenvironment and avert the MET changes in
them. Our study confirmed that MLO-A5 conditioned medium could suppress TMD
cells migration with downregulation of Src and Snail expression. Moreover, MLO-
A5 CM can upregulate p-Akt expression and increase proliferation of breast cancer
cells. However, by applying shear stress to osteocytes, the effects of the conditioned
medium are reversed. Based on the results, MLO-A5 FFCM upregulated Src and
Snail expression, promoted migration, and diminished proliferation. By silencing Src
using Si-RNA and overexpressing Snail by plasmid transfection, it was demonstrated
that fluid flow could stimulate Src and Snail expressions. Furthermore, FRET mea-
surements revealed that MLO-A5 FFCM increases the Src activity and intra-cellular
molecular force in breast cancer cells. In summary, our study suggests that applying
oscillating fluid flow shear stress on osteocytes can alter the bone microenvironment
and creates an EMT-promoting condition for breast cancer cells.
The mechanical properties of the tumor environment can significantly impact on
its progression. For instance, the ECM stiffness can adjust tumor cells and stromal
cells proliferation rate and survival [54]. In addition, studies have shown that in-
creased pressure on tumor cells can also increase their growth in metastatic prostate
cancer patients [55]. All in all, in most cases direct mechanical stimulation of tumor
cells has shown to promote their migratory and invasive behavior [56]. In this study,
no direct mechanical stimulation was applied to cancer cells. However, we investigated
how mechanical stimulation on osteocytes can affect interactions between migratory
breast cancer cells and bone environment. As it was mentioned before, osteocytes re-
ceive 0.8-3 Pa shear stress in vivo because of the pressure gradients due to compressive
forces which stimulate the interstitial fluid through the lacunar-canalicular porosities.
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The pressure gradients can change due to the body activity. For the purpose of this
study, we used oscillatory fluid flow at 1 Hz with 0.2 and 0.8 Pa, since regular daily
activities can create physiologically relevant stress between 0.1 to 1 Pa [39].
Snail is a family of transcription factors which regulate and suppress the expres-
sion of E-cadherin, which makes it one of the critical factors in EMT process [57].
EMT is crucial for breast cancer metastasis, cellular migration, invasion, and in-
travasation. Moreover, recent studies have shown that Snail upregulation can also
contribute to metastasis by induction of immune-suppression [58]. In this research, it
was demonstrated that MLO-A5 conditioned medium could significantly reduce Snail
expression in invasive breast cancer cells. On the contrary, it was shown that MLO-
A5 FF treated conditioned medium can prevent this suppression and contribute to
cancer cells cellular migration and invasion. Studies have shown that different factors
including TGF-β, Notch, Wnt, TNF-α, etc., and cytokines can induce EMT, which
in most cases Snail expression has been found as an EMT marker. Snail can reverse
tumor suppressor effect of TGF-β and promote tumor progression [7]. In addition,
the results from western blot and MTT analysis revealed that MLO-A5 FFCM could
downregulate the expression of p-Akt which can lead to inhibition of proliferation in
cancer cells. All in all, these changes in cancer cells lead to the development of the
notion that MLO-A5 FFCM can inhibit the induction of MET-like responses of MLO-
A5 CM, and in the presence of MLO-A5 FFCM cancer cells are in a more invasive
stage. It has been suggested that the presence of secretory factors such as collagen,
osteonectin, and biglycan are responsible for the MET-like responses of breast cancer
cells in the presence of MLO-A5 CM [59]. However, the underlying mechanism of
how collagen can induce MET in cancer cells, and how MLO-A5 FFCM can suppress
the effect of MLO-A5 CM are not clear. Taken together, while it seems MLO-A5 cells
provide a nurturing environment for tumor cells, mechanical interference completely
changes these characteristics and prevents the MET induction of MLO-A5 CM.
While it seems that tumor cells are sensitive to the amount of pressure, and the
mechanical properties of their microenvironment [60], we observed that the lower
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amount of shear stress applied to MLO-A5 osteocytes leads to the same effects as
higher amount of shear stress. Thus, it seems that at this order, the osteocytes re-
sponse is independent of the amount of fluid shear stress. These results raise the pos-
sibility that even consistent low-intensity physical activity in breast cancer patients
might change the bone metastases process and tumor bone interactions. However,
further investigation is needed to understand the pressure dose response of the osteo-
cytes fully. Moreover, only 1-hour time point has been addressed in this study, and
more analysis is needed to check the efficacy of other time points and both osteocytes
and tumor cells response.
In addition to MDA-MB-231 human breast cancer cell line, our results indicated
that MLO-A5 FFCM could induce the same effect on 4T1 cells which are murine
breast cancer cell line. This observation shows that while cross-species effect might
play a role in cells and conditioned medium interactions, the effect of MLO-A5 FFCM
is independent of the type of the cancer cell line. Based on Shengzhi et al. report,
MLO-A5 CM can induce the similar MET-like responses in 4T1 cells including Snail
downregulation and p-Akt upregulation [61]. In this thesis, we intensively investi-
gated MLO-A5 osteocytes and TMD cells interactions, however, different cell types
might show different characteristics. For instance, it has been shown that MLO-
Y4 osteocytes (mature osteocytes) conditioned medium, can shrink tumor spheroids
more extensively compared to MLO-A5 osteocytes conditioned medium [59]. More-
over, TMD cells seem to show more migratory behavior than BMD cells. Future
investigations are needed to illustrate the cell types impact on these interactions and
fluid flow effect.
We hypothesized that Wnt signaling could be the critical player of tumor behav-
ioral alterations to MLO-A5 FFCM. The results showed that adding Wnt3a causes
tumor spheroid expansion and increase the migration. Moreover, it was shown that
Wnt3a could also upregulate Snail expression in breast cancer cells. While, XAV agent
as oppose to Wnt3a, caused tumor spheroid shrinkage, decreased cellular migration
rate, and downregulated the Snail expression. Thus, it strengthened our notion that
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Wnt3a is extensively involved of the effect we was seeing. However, β-catenin and
Lrp5 expressions of MLO-A5 CM and MLO-A5 FFCM treated cells showed that Wnt
signaling is less likely to be involved in these changes. As it is presented, no significant
changes were seen in the expression of β-catenin and p-β-catenin. Moreover, the Lrp5
expression is significantly upregulated by the MLO-A5 FFCM. However, Wnt3a as a
Wnt stimulator downregulated Lrp5 expression. In addition, in contrast to the effect
of MLO-A5 FFCM, Wnt3a increased the proliferation rate in tumor cells while XAV
decreased it. All in all, the data suggested that something other than Wnt signaling
is involved in these behavioral alterations.
Src is a non-receptor tyrosine kinase. By silencing Src using Src si-RNA, our study
confirmed that Src is upstream of Snail which is crucial for EMT and metastasis pro-
motion [62]. Moreover, the p-FAK expression was changed with p-Src. Furthermore,
studies have shown that Src plays a vital role in cancer progression [63]. Src can be
activated by cytokine and growth factors. In addition, mechanical stimulation can
increase Src activities by ECM-integrin interactions [51]. Since no direct mechanical
stimulation was applied to cancer cells, we hypothesized that fluid flow shear stress
had changed levels of growth factors or cytokines such as TGFβ, in the conditioned
medium. To test this hypothesis, different proteins expressions were studied in osteo-
cytes with and without fluid flow treatment. The results showed that TGF-β expres-
sion in osteocytes is upregulated due to flow. However, no significant changes were
seen in other proteins expression which could potentially affect the tumor-osteocytes
interactions including BMP2, and S100A. The ELISA assay results revealed that
TGF-β concentration is higher in MLO-A5 FFCM which confirmed our notion about
TGF-β involvement in EMT-like responses of tumor cells. Focal adhesions play a
critical role in cellular migration, by interacting with ECM-integrin complexes [64].
Our FRET assay showed that Src activity along with vinculin-based molecular force,
which is a protein in focal adhesions, are altered with conditioned medium. These
results suggest that mechanical stimulation can change cytokines secretion such as
TGF-β in osteocytes which can change the bone microenvironment. Furthermore,
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these cytokines can interact with Src associated integrin receptors on tumor cells and
change their gene expression profile and prevent MLO-A5 CM MET-like responses.
Lrp5 which is a co-receptor with Lrp6 and Frizzled proteins, is mainly involved in
canonical Wnt signaling pathway. However, it roles in tumor progression and metas-
tasis are not clear. Studies have shown that Lrp5 expression suppresses breast tumor
metastasis [65]. However, its downregulation in prostate cancer leads to inclined mi-
gration, invasion, and MET-like response [66]. In this study, our results revealed that
MLO-A5 FFCM, can stimulate Lrp5 expression while MLO-A5 conditioned medium
without any treatment leads to downregulation of Lrp5 and induce a MET-like re-
sponse in breast cancer cells. Furthermore, we showed that silencing Src can cause
an increase in Lrp5 expressions, which suggests Src activity prevents Lrp5.
Fig. 4.1.: Effect of fluid flow treatment on osteocyte conditioned medium and tumor
cells protein expression. Osteocyte conditioned medium blocked p-Src and LRP5
expression, which lead to Snail downregulation and p-Akt upregulation. However,
fluid flow treatment blocked osteocyte conditioned medium effect.
In order to study the effect of mechanical stimulation on physiological and clini-
cal conditions, a study of mouse tibia loading was conducted. Previous studies have
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shown that tibia loading can prevent neovascularization and stop tumor progression in
loading bones [47]. Our results showed that the mechanical stimulation by tibia com-
pression could potentially alter the tumor-osteocytes interactions. Based on Lynch
et al. report tibia loading of SCID mice with MDA-MB-231 tibial injection model,
can significantly change the cancer cells behavior in the bone environment causing a
significant decrease in tumor formation, and increase in bone formation [47]. How-
ever, our results indicated that direct mechanical stimulation can cause damage to
the metastasized tibia, and increase the knee joint fragility. Furthermore, our results
suggested that these loading conditions might lead to more fractures in bone. It is
important to note that, many factors and parameters are involved in vivo tumor-bone
interactions which are not considered in the in vitro model. Moreover, tumor cell line
and mouse strain used may effect the conditions and results. In this study, 4T1.2 tu-
mor cell line and BALB/c mouse strain were used. Our animal study results showed
both osteoblastic and osteolytic activities in both loading and sham loading mice. Our
data analysis suggests that tibia loading might not be beneficial for tumor affected
bones, and cause tumor cells to be more aggressive and invasive. However, further
investigation is needed to truly understand the effect of mechanical stimulation in
vivo.
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5. CONCLUSIONS
The work in this thesis demonstrates the effect of mechanical stimulation on the
bone microenvironment and how it can alter the tumor-osteocytes interactions. Our
in vitro study using fluid flow shear stress on osteocytes, showed mechanical stimu-
lation between 0.2-0.8 Pa could changes the characteristics of MLO-A5 conditioned
medium. While MLO-A5 conditioned medium without treatment can induce MET-
like responses in tumor cells, fluid flow treatment can inhibit this effect. As a result,
tumor cells were more migratory, and less proliferative. Furthermore, this study
showed the crucial role of Src activation in tumor cells in response to changes in os-
teocytes conditioned medium due to mechanical stimulation. In addition, the role of
TGF-β upregulation and its role in response to mechanical stimulation and tumor-
osteocytes interactions has been presented. Our in vivo study indicated that tibia
loading of a tibia bone metastasis mouse model might not be advantageous, and fur-
ther investigation is needed. It is important to note that the loading conditions are
very important, and might change the treatment outcome.
It is important to note that, while the presented results showed the significant
effect of mechanical stimulation on tumor-osteocytes interactions, there are a few lim-
itations that need to be considered. Even though we have investigated both mouse
and human cancer cells in our study, mouse bone cells and human cancer cells were
used as the primary models, and cross-species interactions should be noted. For fu-
ture studies, deeper investigation in MLO-A5 CM, and FFCM components and other
proteins involved using more elaborated assays such as mass spectrometry, can help
better understanding the underlying mechanism of fluid flow treatment. Further-
more, a 3D model which can replicate the bone environment might illustrate the role
of mechanical stimulation better. Also, further investigation of in vivo mechanical
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stimulation is needed to show the efficacy of mechanical stimulation in helping bone
metastasis patients.
In conclusion, the results from this study suggest that tumor cells and osteocytes
conditioned medium interactions completely changes when osteocytes are treated with
fluid flow. The results of the tumor-osteocyte signaling can help future studies to
understand the underlying mechanism of mechanical stimulation better. Also, it can
be used in developing novel therapies and future guidelines of physical therapy to
cure or prevent bone metastasis in breast cancer patients.
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APPENDIX
MATLAB script for stiffness measurement:
clear;
clc;
d=dir(’C:\Users\Aydin\Documents\MATLAB\*.csv’);
n9=length(d)
for ni=1:n9
M=csvread(d(ni).name,54,0,[54 0 14050 5]);
n1=length(M(:,3));
%plot(M(:,2),M(:,5))
o=0;
for i=2:n1
if M(i,3)==0
o=o+1;
v(o)=i;
end
end
v=[1,v,n1];
n2=length(v);
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o1=0;
for i=1:n2-1
x=M(v(i):v(i+1),2);
y=M(v(i):v(i+1),5);
[fmin, imin]=min(y);
yl=length(y);
y(imin:yl)=[];
x(imin:yl)=[];
[fmax, imax]=max(y);
y(1:imax)=[];
x(1:imax)=[];
xlength=length(x);
z=[];
if xlength>0
[D1, II1] = min(abs(M(:,2)-x(1)));
[D2, II2] = min(abs(M(:,2)-x(xlength)));
z=M(II1:II2,6);
end
minf=min(y);
maxf=max(y);
dd=minf-maxf;
f1=dd/4+maxf;
f2=dd/2+maxf;
if xlength>0
[DD1, III1] = min(abs(y-f1));
[DD2, III2] = min(abs(y-f2));
y1=y(III1:III2);
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z1=z(III1:III2);
end
if length(z)>0
o1=o1+1;
sti=polyfit(z1,y1,1);
stif(o1)=sti(:,1);
end
% figure(i)
% plot(z,y);
end
final(:,ni)=stif;
csvwrite(’stiffness.csv’,final);
end
